Quetiapine-induced myoclonus

International Clinical Psychopharmacology

Volumn 20, Issue 2, 2005, Pages 119-120

  Velayudhan, Latha ^a,b   Kirchner, Vincent ^a  

^a CAMDEN AND ISLINGTON NHS FOUNDATION TRUST   (United Kingdom)

^b ST PANCRAS HOSPITAL   (United Kingdom)

Author keywords

Myoclonus; Quetiapine

Indexed keywords

AMISULPRIDE; CHLORPROMAZINE; CITALOPRAM; NEUROLEPTIC AGENT; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; AUDITORY HALLUCINATION; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG MEGADOSE; DYSKINESIA; FOLLOW UP; GRANDIOSE DELUSION; HUMAN; MALE; MYOCLONUS; PARANOID SCHIZOPHRENIA; PARKINSONISM; PRIORITY JOURNAL; SYMPTOM;

ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; HUMANS; MALE; MIDDLE AGED; MYOCLONUS; SCHIZOPHRENIA, PARANOID;

EID: 14844348445     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200503000-00011     Document Type: Article

References (13)

1. Amann BL, Pogarell O, Mergl R, Juckel G, Grunze H, Mulert C, Hegerl U (2003). EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects. Hum Psychopharmacol 18:641-646.
2. Bak TH, Bauer M, Schaub RT, Hellweg R, Reischies FM (1995). Myoclonus in patients with clozapine: a case series. J Clin Psychiatry 56:418-422.
3. Barak Y, Levine J, Weisz R (1996). Clozapine-lnduced Myoclonus: two case reports. J Clin Psychopharmacol 16:339-340.
4. DeVane CL, Nemeroff CB (2001). Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. Clin Pharmacokinet 40:509-522.
5. Dogu O, Sevim S, Kaleagasi HS (2003). Seizures associated with quetiapine treatment. Annal Pharmacother 37:1224-12247.
6. Folstein MF, Folstein SE, McHugh PR (1975). 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
7. Goldstein JM (1999). Quetiapine fumarate (Seroquel): a new atypical antipsychotic. Drugs Today (Barcelona) 35:193-210.
8. Hagan JJ, Hatcher JP, Slade P (1995). The role of 5-HT1D and 5-HT1A receptors in mediating 5-hydroxytryptophan induced myoclonic jerks in guinea pigs. Eur J Pharmacol 294:743-751.
9. Jimenez-Jimenez FJ, Puertas I, de Toledo-Heras MD (2004). Drug-induced myoclonus: frequency, mechanisms and management. CNS Drugs 18:93-104.
10. Srisurapanont M, Maneeton B, Maneeton N (2004). Cochrane Database Sys Rev 2:CD000967.
11. Tariot PN, Ismail MS (2002). Use of quetiapine in elderly patients. J Clin Psychiatry 63 (suppl 13):21-26.
12. Welsh JP, Placantonakis DG, Warsetsky SI, Marquez RG, Bernstein L, Aicher SA (2002). The serotonin hypothesis of myoclonus from the perspective of neuronal rhythmicity. Adv Neurol 89:307-329.
13. Wijnen HH, van der Heijden FM, van Schendel FM, Tuinier S, Verhoeven WM (2003). Quetiapine in the elderly with parkinsonism and psychosis. Eur Psychiatry 18:372-373.